封面
市场调查报告书
商品编码
1575009

青霉素药物市场,按类型、按给药途径、按应用、按最终用户、按国家和地区划分 - 2024-2032 年行业分析、市场规模、市场份额和预测

Penicillin Drug Market, By Type, By Route of Administration, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日期: | 出版商: AnalystView Market Insights | 英文 269 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告要点

2023年青霉素药物市场规模为91.0232亿美元,2024年至2032年复合年增长率为4.20%。

青霉素药品市场-市场动态

抗生素处方的增加推动了青霉素药物市场的成长

在细菌感染增加和人口老化的推动下,抗生素处方的增加极大地推动了青霉素药物市场的发展。据世界卫生组织称,抗生素抗药性是一个重大的全球健康问题,导致对有效治疗的需求更高。 2021 年,美国疾病管制与预防中心报告称,仅在美国,每年的抗生素处方就超过 2 亿张,其中青霉素衍生物仍然是治疗链球菌性咽喉炎和肺炎等疾病的重要选择。这一趋势得到了对新型製剂和递送方法的持续研究的补充,从而增强了基于青霉素的疗法的功效。随着医疗保健提供者努力应对不断上升的抗药性率,对适当抗生素使用的重视将进一步推动市场成长,为製药公司在这一重要治疗领域创新和扩大其产品组合提供机会。

青霉素药物市场 - 主要见解

根据我们的研究分析师分享的分析,预计全球市场在预测期内(2024-2032 年)每年将以 4.20% 左右的复合年增长率成长

根据类型细分,预计氨青霉素将在 2023 年显示最大的市场份额

根据给药途径细分,注射剂是 2023 年的主导类型

按应用细分,2023年呼吸道感染为主导类型

按地区划分,北美是 2023 年的主要收入来源

青霉素药物市场-細項分析:

全球青霉素药物市场根据类型、给药途径、应用、最终用户和地区进行细分。

市场依类型分为四类:天然青霉素、氨基青霉素、抗青霉素酶青霉素和广谱青霉素。由于其广谱功效,预计氨基青霉素将占据最高的市场份额,其次是对治疗抗药性感染至关重要的广谱青霉素。天然青霉素和抗青霉素酶青霉素优先。

根据给药途径,市场分为两类:口服和注射。注射剂型因其在严重感染中的快速作用和有效性而被优先考虑,而口服製剂也因其在门诊环境中的方便性和易用性而具有重要意义,紧随其后。

青霉素药品市场-地理洞察

青霉素药物市场呈现出显着的区域差异,其中北美由于其先进的医疗基础设施和高抗生素消费率而处于领先地位。美国占了很大的份额,每年开出超过 6,000 万份青霉素类抗生素处方。欧洲紧随其后,德国和英国等国家实施了严格的法规,促进负责任的抗生素使用,但报告的使用水平仍然很高。在亚太地区,医疗保健支出的增加和对传染病认识的提高正在推动成长,其中中国是主要参与者,随着城市化和工业化的发展,抗生素消费量激增。此外,印度的倡议,例如改善基本药物的获取,也提振了青霉素药物的市场。拉丁美洲也展现出潜力,巴西专注于扩大其药品製造能力。每个地区独特的医疗保健动态和监管框架都会影响对青霉素的需求,因此公司根据当地市场条件调整策略至关重要。

青霉素药品市场-竞争格局:

青霉素药品市场的竞争格局由各地区的主要参与者组成,每位参与者都有独特的优势。在北美,辉瑞和默克是主要贡献者,得益于先进的研发能力,辉瑞每年生产超过2000万单位的青霉素。欧洲是葛兰素史克 (GlaxoSmithKline) 和罗氏 (Roche) 等公司的所在地,这些公司专注于创新和遵守严格的法规;葛兰素史克最近发起了一项运动,以促进整个欧盟负责任地使用抗生素。在亚太地区,湖南金字药业和浙江华海药业已成为重要参与者,应对抗生素需求的不断增长,特别是在中国,该市场预计每年增长10%。拉丁美洲正在见证巴西 Farmanguinhos 等当地製造商的成长,该公司正在扩大生产以满足当地的医疗保健需求。这些参与者不断投资于研究和合作伙伴关係,以增强其市场地位并应对抗生素抗药性的全球挑战,同时满足不同的区域需求。

最新进展:

2024年6月,Orchid Pharma与Cipla合作推出了一种新型抗生素头孢吡肟-恩美唑巴坦,针对复杂的泌尿道感染和肺炎。这项合作关係旨在对抗抗菌药物抗药性并确保在印度各地快速分发,从而显着改善医疗保健效果。

2024 年 6 月,Wockhardt 计划于 25 财年末在印度推出其新型抗生素 Zaynich。该药物针对抗药性感染,在富有同情心的使用案例中显示出 100% 的成功率。预计它将解决全球重大的抗菌素抗药性问题。

目录

第一章:青霉素药物市场概述

  • 研究范围
  • 市场预估年份

第 2 章:执行摘要

  • 市场片段
    • 青霉素药物市场摘要(按类型)
    • 按给药途径分類的青霉素药物市场摘要
    • 青霉素药物市场片段(依应用)
    • 最终用户的青霉素药物市场片段
    • 按国家/地区分類的青霉素药物市场摘要
    • 按地区分類的青霉素药物市场片段
  • 竞争洞察

第 3 章:青霉素药物主要市场趋势

  • 青霉素药物市场驱动因素
    • 市场驱动因素的影响分析
  • 青霉素药品市场限制
    • 市场限制影响分析
  • 青霉素药物市场机会
  • 青霉素药物市场未来趋势

第 4 章:青霉素药品工业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章:青霉素药物市场:COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章:青霉素药物市场格局

  • 2023 年青霉素药物市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章:青霉素药物市场 - 按类型

  • 概述
    • 按类型分類的细分市场占有率分析
    • 天然青霉素
    • 氨基青霉素
    • 青霉素酶抗性青霉素
    • 广谱青霉素

第 8 章:青霉素药物市场 - 依给药途径

  • 概述
    • 按给药途径分類的细分市场份额分析
    • 口服
    • 可注射

第 9 章:青霉素药物市场 - 按应用

  • 概述
    • 按应用分類的细分市场占有率分析
    • 呼吸道感染
    • 泌尿道感染 (UTI)
    • 皮肤和软组织感染
    • 性传染感染

第 10 章:青霉素药物市场 - 按最终用户

  • 概述
    • 按给药途径分類的细分市场份额分析
    • 医院
    • 诊所
    • 家庭护理设置
    • 零售药局

第 11 章:青霉素药物市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美青霉素药物主要製造商
    • 北美市场规模和预测(按国家)
    • 北美市场规模和预测(按类型)
    • 北美市场规模与预测(按管理途径)
    • 北美市场规模和预测(按应用)
    • 北美市场规模和预测(按最终用户)
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲青霉素药物主要製造商
    • 欧洲市场规模和预测(按国家)
    • 欧洲市场规模与预测(按类型)
    • 欧洲市场规模与预测(按管理途径)
    • 欧洲市场规模和预测(按应用)
    • 欧洲市场规模和预测(按最终用户)
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区青霉素药物主要製造商
    • 亚太地区市场规模与预测(按国家)
    • 亚太地区市场规模与预测(按类型)
    • 亚太地区市场规模与预测(依管理途径)
    • 亚太地区市场规模与预测(按应用)
    • 亚太地区市场规模和预测(按最终用户)
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲青霉素药物主要製造商
    • 拉丁美洲市场规模与预测(按国家)
    • 拉丁美洲市场规模与预测(按类型)
    • 拉丁美洲市场规模与预测(按管理途径)
    • 拉丁美洲市场规模与预测(按应用)
    • 拉丁美洲市场规模和预测(按最终用户)
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲青霉素药物主要製造商
    • 中东和非洲市场规模及预测(按国家)
    • 中东和非洲市场规模及预测(按类型)
    • 中东和非洲市场规模及预测(按管理途径)
    • 中东和非洲市场规模及预测(按应用)
    • 中东和非洲市场规模和预测(按最终用户)
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 12 章:主要供应商分析 - 青霉素药品产业

  • 竞争仪表板
  • 公司简介
    • Alembic Pharmaceuticals Ltd.
    • Aurobindo Pharma Limited
    • Fresenius Kabi AG
    • GlaxoSmithKline plc
    • Hikma Pharmaceuticals PLC
    • Lupin Limited
    • Merck & Co., Inc.
    • Mylan NV (Viatris)
    • Novartis International AG
    • Pfizer Inc.
    • Sandoz International GmbH
    • Sanofi SA
    • Sun Pharmaceutical Industries Ltd.
    • Teva Pharmaceutical Industries Ltd.
    • Wockhardt Limited
    • Zydus Lifesciences Ltd.
    • Others

第 13 章:360 度分析师视角

第 14 章:附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV4004

REPORT HIGHLIGHT

Penicillin Drug Market size was valued at USD 9,102.32 Million in 2023, expanding at a CAGR of 4.20% from 2024 to 2032.

The Penicillin Drug Market encompasses a range of antibiotics derived from Penicillium fungi, primarily used to treat bacterial infections. The increasing prevalence of bacterial infections and the rise in antibiotic prescriptions are major factors contributing to market growth. Additionally, initiatives from organizations like the World Health Organization to combat antibiotic resistance are pushing for greater availability and innovation in penicillin-based treatments. However, challenges such as the growing incidence of antibiotic resistance and stringent regulatory frameworks can restrain market expansion. Opportunities lie in the development of new formulations and combination therapies, as well as rising demand in emerging markets. For instance, the use of penicillin in treating syphilis and rheumatic fever continues to be endorsed by health authorities, highlighting its enduring relevance in modern medicine.

Penicillin Drug Market- Market Dynamics

Rise in Antibiotic Prescriptions Fuels Growth in the Penicillin Drug Market

The rise in antibiotic prescriptions is significantly boosting the Penicillin Drug Market, driven by increasing bacterial infections and a growing aging population. According to the World Health Organization, antibiotic resistance is a major global health issue, leading to higher demand for effective treatments. In 2021, the Centers for Disease Control and Prevention reported that antibiotic prescriptions exceeded 200 million annually in the U.S. alone, with penicillin derivatives remaining a crucial choice for treating conditions such as strep throat and pneumonia. This trend is complemented by ongoing research into novel formulations and delivery methods, enhancing the efficacy of penicillin-based therapies. As healthcare providers strive to combat rising resistance rates, the emphasis on appropriate antibiotic use will further propel the market's growth, presenting opportunities for pharmaceutical companies to innovate and expand their portfolios in this essential therapeutic area.

Penicillin Drug Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.20% over the forecast period (2024-2032)

Based on Type segmentation, Aminopenicillins was predicted to show maximum market share in the year 2023

Based on Route of Administration segmentation, Injectable was the leading type in 2023

Based on Application segmentation, Respiratory Tract Infections was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Penicillin Drug Market- Segmentation Analysis:

The Global Penicillin Drug Market is segmented on the basis of Type, Route of Administration, Application, End-User, and Region.

The market is divided into four categories based on Type: Natural Penicillin, Aminopenicillins, Penicillinase-Resistant Penicillin, and Extended-Spectrum Penicillin. Aminopenicillins are expected to hold the highest market share due to their broad-spectrum efficacy, followed by Extended-Spectrum Penicillin, which is crucial for treating resistant infections. Natural Penicillin and Penicillinase-Resistant Penicillin follow in priority.

The market is divided into two categories based on Route of Administration: Oral and Injectable. Injectable forms are prioritized due to their rapid action and effectiveness in severe infections, while Oral formulations are also significant for their convenience and ease of use in outpatient settings, following closely in preference.

Penicillin Drug Market- Geographical Insights

The Penicillin Drug Market exhibits notable regional variations, with North America leading due to its advanced healthcare infrastructure and high antibiotic consumption rates. The U.S. accounts for a significant share, with over 60 million prescriptions for penicillin-based antibiotics annually. Europe follows closely, where countries like Germany and the UK have implemented stringent regulations promoting responsible antibiotic use, yet still report high usage levels. In Asia-Pacific, rising healthcare expenditures and increased awareness of infectious diseases are driving growth, with China being a key player, where antibiotic consumption has surged in response to urbanization and industrialization. Additionally, initiatives in India, such as improving access to essential medicines, have bolstered the market for penicillin drugs. Latin America shows potential as well, with Brazil focusing on expanding its pharmaceutical manufacturing capabilities. Each region's unique healthcare dynamics and regulatory frameworks influence the demand for penicillin, making it crucial for companies to tailor their strategies to capitalize on local market conditions.

Penicillin Drug Market- Competitive Landscape:

The competitive landscape of the Penicillin Drug Market is characterized by major players across various regions, each leveraging unique strengths. In North America, Pfizer and Merck are key contributors, with Pfizer producing over 20 million units of penicillin annually, benefiting from advanced research and development capabilities. Europe is home to companies like GlaxoSmithKline and Roche, which focus on innovation and compliance with stringent regulations; GSK recently launched a campaign to promote responsible antibiotic usage across the EU. In the Asia-Pacific region, Hunan Jinzi Pharmaceutical and Zhejiang Huahai Pharmaceutical have emerged as significant players, responding to the rising demand for antibiotics, particularly in China, where the market is projected to grow by 10% annually. Latin America is witnessing growth from local manufacturers such as Farmanguinhos in Brazil, which is expanding its production to meet local healthcare needs. These players are continuously investing in research and partnerships to enhance their market positions and address the global challenge of antibiotic resistance while meeting diverse regional demand.

Recent Developments:

In June 2024, Orchid Pharma launched a new antibiotic, Cefepime-Enmetazobactam, in collaboration with Cipla, targeting complicated urinary tract infections and pneumonia. This partnership aims to combat antimicrobial resistance and ensure rapid distribution across India, enhancing healthcare outcomes significantly.

In June 2024, Wockhardt plans to launch its novel antibiotic Zaynich in India by the end of FY25. This drug targets drug-resistant infections and has shown a 100% success rate in compassionate use cases. It is expected to address significant antimicrobial resistance issues globally.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PENICILLIN DRUG MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Alembic Pharmaceuticals Ltd.
  • Aurobindo Pharma Limited
  • Fresenius Kabi AG
  • GlaxoSmithKline plc
  • Hikma Pharmaceuticals PLC
  • Lupin Limited
  • Merck & Co., Inc.
  • Mylan N.V. (Viatris)
  • Novartis International AG
  • Pfizer Inc.
  • Sandoz International GmbH
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Wockhardt Limited
  • Zydus Lifesciences Ltd.
  • Others

GLOBAL PENICILLIN DRUG MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Natural Penicillins
  • Aminopenicillins
  • Penicillinase-Resistant Penicillins
  • Extended-Spectrum Penicillins

GLOBAL PENICILLIN DRUG MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032

  • Oral
  • Injectable

GLOBAL PENICILLIN DRUG MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Respiratory Tract Infections
  • Urinary Tract Infections (UTIs)
  • Skin and Soft Tissue Infections
  • Sexually Transmitted Infections

GLOBAL PENICILLIN DRUG MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Clinics
  • Homecare Settings
  • Retail Pharmacies

GLOBAL PENICILLIN DRUG MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Penicillin Drug Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Penicillin Drug Market Snippet by Type
    • 2.1.2. Penicillin Drug Market Snippet by Route of Administration
    • 2.1.3. Penicillin Drug Market Snippet by Application
    • 2.1.4. Penicillin Drug Market Snippet by End-User
    • 2.1.5. Penicillin Drug Market Snippet by Country
    • 2.1.6. Penicillin Drug Market Snippet by Region
  • 2.2. Competitive Insights

3. Penicillin Drug Key Market Trends

  • 3.1. Penicillin Drug Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Penicillin Drug Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Penicillin Drug Market Opportunities
  • 3.4. Penicillin Drug Market Future Trends

4. Penicillin Drug Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Penicillin Drug Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Penicillin Drug Market Landscape

  • 6.1. Penicillin Drug Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Penicillin Drug Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2. Natural Penicillins
    • 7.1.3. Aminopenicillins
    • 7.1.4. Penicillinase-Resistant Penicillins
    • 7.1.5. Extended-Spectrum Penicillins

8. Penicillin Drug Market - By Route of Administration

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Route of Administration, 2023 & 2032 (%)
    • 8.1.2. Oral
    • 8.1.3. Injectable

9. Penicillin Drug Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 9.1.2. Respiratory Tract Infections
    • 9.1.3. Urinary Tract Infections (UTIs)
    • 9.1.4. Skin and Soft Tissue Infections
    • 9.1.5. Sexually Transmitted Infections

10. Penicillin Drug Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Clinics
    • 10.1.4. Homecare Settings
    • 10.1.5. Retail Pharmacies

11. Penicillin Drug Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Penicillin Drug Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Penicillin Drug Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Penicillin Drug Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Penicillin Drug Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Penicillin Drug Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Penicillin Drug Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Alembic Pharmaceuticals Ltd.
    • 12.2.2. Aurobindo Pharma Limited
    • 12.2.3. Fresenius Kabi AG
    • 12.2.4. GlaxoSmithKline plc
    • 12.2.5. Hikma Pharmaceuticals PLC
    • 12.2.6. Lupin Limited
    • 12.2.7. Merck & Co., Inc.
    • 12.2.8. Mylan N.V. (Viatris)
    • 12.2.9. Novartis International AG
    • 12.2.10. Pfizer Inc.
    • 12.2.11. Sandoz International GmbH
    • 12.2.12. Sanofi S.A.
    • 12.2.13. Sun Pharmaceutical Industries Ltd.
    • 12.2.14. Teva Pharmaceutical Industries Ltd.
    • 12.2.15. Wockhardt Limited
    • 12.2.16. Zydus Lifesciences Ltd.
    • 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us